-
1by Fedewa, Stacey A Goodman, Michael Flanders, W. Dana Han, Xuesong Smith, Robert A M. Ward, Elizabeth Doubeni, Chyke A Sauer, Ann Goding Jemal, Ahmedin Published in Cancer (15.09.2015)“...BACKGROUND The aim of the cost‐sharing provision of the Patient Protection and Affordable Care Act (ACA) was to reduce financial barriers for preventive...”
-
2by Ross-Degnan, Dennis Wallace, Jamie Zhang, Fang Soumerai, Stephen B Garabedian, Laura Wharam, J Frank Published in Medical care (01.06.2020)“...BACKGROUND:High deductible health plans linked to Health Savings Accounts (HSA-HDHPs) must include all care under the deductible except for select preventive...”
-
3by Dusetzina, Stacie B Conti, Rena M Yu, Nancy L Bach, Peter B Published in JAMA internal medicine (01.08.2017)“...The increasing cost of prescription drugs is a burden for patients and threatens the financial stability of the US health care system. Rebates are a form of...”
-
4by Doshi, Jalpa A Hu, Tianyan Li, Pengxiang Pettit, Amy R Yu, Xinyan Blum, Marissa Published in Arthritis care & research (2010) (01.11.2016)“...Objective To examine associations between specialty tier‐level cost sharing and use of biologic agents for rheumatoid arthritis (RA) during Medicare Part D's...”
-
6by Robinson, James C Brown, Timothy Whaley, Christopher Published in Health affairs (Project Hope) (01.03.2015)“...Some employers are using reference-based benefit (RBB) designs, also known as "reference-based pricing," to encourage patients to select lower-price ambulatory...”
-
7by Li, Qijuan Keohane, Laura M Thomas, Kali Lee, Yoojin Trivedi, Amal N Published in JAMA internal medicine (01.07.2017)“...IMPORTANCE: Several policy proposals advocate introducing copayments for home health care in the Medicare program. To our knowledge, no prior studies have...”
-
8by Starner, Catherine I Alexander, G Caleb Bowen, Kevin Qiu, Yang Wickersham, Peter J Gleason, Patrick P Published in Health affairs (Project Hope) (01.10.2014)“...Expenditures for specialty drugs account for more than 25 percent of total US drug spending and have been increasing at more than 13 percent annually. We...”
-
9by Kwong, Kien Seang Choo, Yai Wen Cheah, Huey Miin Published in Value in health regional issues (01.05.2020)“...To calculate the total revenue under a hypothetical 1 Malaysian Ringgit (MYR) prescription cost sharing model in government healthcare facilities in Pahang,...”
-
10by Lemaire, Robin H Bailey, Linda Leischow, Scott J Published in American journal of public health (1971) (01.11.2015)“...We explored whether various key stakeholders considered cost sharing with state telephone-based tobacco cessation quitlines, because including tobacco...”
-
11“...There are positive and negative consequences of the implementation of out of pocket (OOP) payments as a source of the healthcare financing. On the one hand,...”
-
12by Thomson, Sarah Schang, Laura Chernew, Michael E Published in Health affairs (Project Hope) (01.04.2013)“...This article reviews efforts in the United States and several other member countries of the Organization for Economic Cooperation and Development to encourage...”
-
13“...ABSTRACT Pay for performance (P4P) incentives for physicians are generally designed as additional payments that can be paired with any existing payment...”
-
14“...The burden of cancer on public finances is a serious concern for policy makers. More people are developing cancer, and as standards of care have risen, more...”
-
15by Dickey, H Ikenwilo, D Norwood, P Watson, V Zangelidis, A Published in Social science & medicine (1982) (01.02.2016)“...Preventive health care is promoted by many organisations from the World Health Organisation (WHO) to regional and national governments. The degree of...”
-
16“...The value of "specialty pharmaceuticals" for cancer and other complex conditions depends not merely on their molecular structures but also on the manner in...”
-
17by Matthew B. Frank A. Mark Fendrick Yulei He Arthur Zbrozek Norma Holtz Simon Leung Michael E. Chernew Published in Medical care (01.11.2012)“...Background: Cost-sharing requirements employed by health insurers to discourage the unnecessary use of medications may lead to underutilization of recommended...”
-
18
-
19by Selden, Thomas M Kenney, Genevieve M Pantell, Matthew S Ruhter, Joel Published in Health Affairs (01.07.2009)“...Rapidly rising spending has prompted debate about increasing cost sharing in Medicaid and the Children's Health Insurance Program (CHIP). In this paper we...”
-
20by Sacks, Naomi C Burgess Jr, James F Cabral, Howard J Pizer, Steven D McDonnell, Marie E Published in Journal of general internal medicine : JGIM (01.07.2013)“...Although the Medicare Part D coverage gap phase-out should reduce cost-related nonadherence (CRN) among seniors with diabetes, preferential generic prescribing...”